Auxly Cannabis Group Stock Beta
| XLY Stock | CAD 0.04 0.01 12.50% |
Auxly Cannabis Group fundamentals help investors to digest information that contributes to Auxly Cannabis' financial success or failures. It also enables traders to predict the movement of Auxly Stock. The fundamental analysis module provides a way to measure Auxly Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Auxly Cannabis stock.
Auxly | Beta |
Auxly Cannabis Group Company Beta Analysis
Auxly Cannabis' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Auxly Cannabis Beta | 1.22 |
Most of Auxly Cannabis' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Auxly Cannabis Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Auxly Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Auxly Cannabis is extremely important. It helps to project a fair market value of Auxly Stock properly, considering its historical fundamentals such as Beta. Since Auxly Cannabis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Auxly Cannabis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Auxly Cannabis' interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Auxly Cannabis Group has a Beta of 1.223. This is 42.21% higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The beta for all Canada stocks is notably lower than that of the firm.
Auxly Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Auxly Cannabis' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Auxly Cannabis could also be used in its relative valuation, which is a method of valuing Auxly Cannabis by comparing valuation metrics of similar companies.Auxly Cannabis is currently under evaluation in beta category among its peers.
Auxly Cannabis Current Valuation Drivers
We derive many important indicators used in calculating different scores of Auxly Cannabis from analyzing Auxly Cannabis' financial statements. These drivers represent accounts that assess Auxly Cannabis' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Auxly Cannabis' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 322.1M | 161.0M | 144.9M | 17.8M | 9.9M | 9.4M | |
| Enterprise Value | 377.7M | 264.5M | 320.3M | 196.8M | 152.8M | 80.4M |
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Auxly Cannabis will likely underperform.
Auxly Fundamentals
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.0309 | ||||
| Profit Margin | (0.41) % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 96.4 M | ||||
| Shares Outstanding | 1.25 B | ||||
| Shares Owned By Insiders | 21.73 % | ||||
| Shares Owned By Institutions | 0.24 % | ||||
| Number Of Shares Shorted | 348.01 K | ||||
| Price To Book | 0.39 X | ||||
| Price To Sales | 0.41 X | ||||
| Revenue | 101.08 M | ||||
| Gross Profit | 19.29 M | ||||
| EBITDA | (30.95 M) | ||||
| Net Income | (44.51 M) | ||||
| Cash And Equivalents | 14.64 M | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 159.04 M | ||||
| Debt To Equity | 1.20 % | ||||
| Current Ratio | 2.58 X | ||||
| Book Value Per Share | 0.05 X | ||||
| Cash Flow From Operations | 8.21 M | ||||
| Short Ratio | 0.88 X | ||||
| Earnings Per Share | (0.07) X | ||||
| Target Price | 0.02 | ||||
| Number Of Employees | 369 | ||||
| Beta | 1.22 | ||||
| Market Capitalization | 44.93 M | ||||
| Total Asset | 261.9 M | ||||
| Retained Earnings | (483.27 M) | ||||
| Working Capital | (38.98 M) | ||||
| Net Asset | 261.9 M |
About Auxly Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Auxly Cannabis Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Auxly Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Auxly Cannabis Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in Auxly Stock
Auxly Cannabis financial ratios help investors to determine whether Auxly Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.